Molecular Cognition Laboratory, Department of Psychology, University of California, San Diego, La Jolla, CA 92093-0109, United States.
Behav Brain Res. 2012 Dec 1;235(2):105-12. doi: 10.1016/j.bbr.2012.07.039. Epub 2012 Aug 3.
Modafinil is a wake-promoting drug effective at enhancing alertness and attention with a variety of approved and off-label applications. The mechanism of modafinil is not well understood but initial studies indicated a limited abuse potential. A number of recent publications, however, have shown that modafinil can be rewarding under certain conditions. The present study assessed the reinforcing properties of modafinil using conditioned place preference and locomotor sensitization in mice. Experiment 1 examined a high dose of modafinil (75 mg/kg) as well as its interactions with cocaine (15 mg/kg). Cocaine alone and modafinil co-administered with cocaine induced sensitization of locomotor activity; modafinil alone showed little or no locomotor sensitization. Animals given modafinil alone, cocaine alone, and modafinil plus cocaine exhibited a strong and roughly equivalent place preference. When tested for sensitization using a low challenge dose of modafinil, cross-sensitization was observed in all cocaine-pretreated mice. Experiment 2 examined a low dose of modafinil that is similar to the dose administered to humans and has been shown to produce cognitive enhancements in mice. Low dose modafinil (0.75 mg/kg) did not produce conditioned place preference or locomotor sensitization. Together, these results suggest that modafinil has the potential to produce reward, particularly in cocaine addicts, and should be used with caution. However, the typical low dose administered likely moderates these effects and may account for lack of addiction seen in humans.
莫达非尼是一种促醒药物,能有效提高警觉性和注意力,并有多种已批准和未经批准的用途。莫达非尼的作用机制尚不清楚,但初步研究表明其滥用潜力有限。然而,最近的一些出版物表明,在某些条件下,莫达非尼可能具有奖赏作用。本研究使用条件性位置偏爱和运动敏化来评估莫达非尼的强化特性。实验 1 检查了高剂量的莫达非尼(75mg/kg)及其与可卡因(15mg/kg)的相互作用。单独的可卡因和莫达非尼与可卡因共同给药会引起运动活动的敏化;单独的莫达非尼显示出很少或没有运动敏化。单独给予莫达非尼、可卡因和莫达非尼加可卡因的动物表现出强烈且大致相当的位置偏好。当使用低剂量的莫达非尼进行敏化测试时,所有预先给予可卡因的小鼠都观察到交叉敏化。实验 2 检查了一种类似于人类给予的剂量的低剂量莫达非尼,该剂量已被证明可增强小鼠的认知能力。低剂量莫达非尼(0.75mg/kg)不会产生条件性位置偏好或运动敏化。总之,这些结果表明莫达非尼有可能产生奖赏,特别是在可卡因成瘾者中,应谨慎使用。然而,人类通常给予的低剂量可能会减轻这些影响,这可能是人类未见成瘾的原因。